These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2513286)

  • 1. Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Adcock L; Webster KD; DeEulis T
    Invest New Drugs; 1989 Nov; 7(4):341-3. PubMed ID: 2513286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Homesley HD; McGuire WP; Adcock L
    Cancer; 1994 Mar; 73(5):1453-5. PubMed ID: 8111713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologic Oncology Group experience with ifosfamide.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; DiSaia PJ; McGuire WP
    Gynecol Oncol; 1993 Apr; 49(1):48-50. PubMed ID: 8482560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S55-8. PubMed ID: 2112054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. A phase II trial.
    Cervellino JC; Araujo CE; Sánchez O; Miles H; Nishihama A
    Acta Oncol; 1995; 34(2):257-9. PubMed ID: 7718266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).
    Sutton GP; Blessing JA; Rosenshein N; Photopulos G; DiSaia PJ
    Am J Obstet Gynecol; 1989 Aug; 161(2):309-12. PubMed ID: 2548382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
    Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
    J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
    Sutton GP; Blessing JA; Homesley HD; Berman ML; Malfetano J
    J Clin Oncol; 1989 Nov; 7(11):1672-6. PubMed ID: 2509641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of ifosfamide in cervical cancer.
    Meanwell CA; Mould JJ; Blackledge G; Lawton FG; Stuart NS; Kavanagh J; Latief TN; Spooner D; Chetiyawardana AD
    Cancer Treat Rep; 1986 Jun; 70(6):727-30. PubMed ID: 3089596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix.
    Vallejo CT; Pérez JE; Domínguez ME; Leone BA; Machiavelli MR; Lacava JA; Romero AO; Ortiz EH; Grasso S; Amato S; Rodríguez R; Barbieri M; Romero Acuña J; Focaccia G; Suttora G; Scenna M; Boughen JM; Romero Acuña LA; Langhi MJ
    Am J Clin Oncol; 2000 Oct; 23(5):481-6. PubMed ID: 11039508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Homesley HD; Malfetano JH
    Gynecol Oncol; 1994 Apr; 53(1):24-6. PubMed ID: 8175017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC
    Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.
    Zanetta G; Lissoni A; Pellegrino A; Sessa C; Colombo N; Gueli-Alletti D; Mangioni C
    Ann Oncol; 1998 Sep; 9(9):977-80. PubMed ID: 9818071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
    Cervellino JC; Araujo CE; Pirisi C; Sanchez O; Brosto M; Rossi R
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-3. PubMed ID: 2112052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
    J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
    Kredentser DC
    Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.